Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane M Devine

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
European Journal of Medicinal Chemistry|May 31, 2021
Discovery and development of 2-aminobenzimidazoles as potent antimalarialsShane M Devine, Matthew P Challis, Jomo K Kigotho, et al.
Chemmedchem|January 18, 2019
Identification of the Binding Site of Apical Membrane Antigen 1 (AMA1) Inhibitors Using a Paramagnetic ProbeMansura Akter, Nyssa Drinkwater, Shane M Devine, et al.
Plos Pathogens|September 5, 2025
Divergent resistance pathways amongst SARS-CoV-2 PLpro inhibitors highlight the need for scaffold diversityXinyu Wu, Shane M Devine, Margareta Go, et al.
Journal of Molecular Recognition : JMR|January 26, 2016
Solution NMR characterization of apical membrane antigen 1 and small molecule interactions as a basis for designing new antimalarialsBankala Krishnarjuna, San Sui Lim, Shane M Devine, et al.
Biochemistry|November 1, 2014
Structure and dynamics of apical membrane antigen 1 from Plasmodium falciparum FVOSan Sui Lim, Wei Yang, Bankala Krishnarjuna, et al.
Journal of Medicinal Chemistry|January 7, 2015
Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffoldShane M Devine, Mark D Mulcair, Cael O Debono, et al.
Elife|July 8, 2024
Chemoproteomics validates selective targeting of <i>Plasmodium</i> M1 alanyl aminopeptidase as an antimalarial strategyCarlo Giannangelo, Matthew P Challis, Ghizal Siddiqui, et al.
The EMBO Journal|April 7, 2026
Global analysis of cancer cell responses to USP9X inhibitionPhilipp Schenk, Shane M Devine, Simon A Cobbold, et al.
Nature|April 22, 2026
Ubiquitination of glycogen and metabolites in cells and tissuesMarco Jochem, Simon A Cobbold, Craig A Goodman, et al.
Nature Communications|April 3, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVIDStefanie M Bader, Dale J Calleja, Shane M Devine, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Journal of Medicinal Chemistry|May 31, 2021
Discovery and development of 2-aminobenzimidazoles as potent antimalarialsShane M Devine, Matthew P Challis, Jomo K Kigotho, et al.
Chemmedchem|January 18, 2019
Identification of the Binding Site of Apical Membrane Antigen 1 (AMA1) Inhibitors Using a Paramagnetic ProbeMansura Akter, Nyssa Drinkwater, Shane M Devine, et al.
Plos Pathogens|September 5, 2025
Divergent resistance pathways amongst SARS-CoV-2 PLpro inhibitors highlight the need for scaffold diversityXinyu Wu, Shane M Devine, Margareta Go, et al.
Journal of Molecular Recognition : JMR|January 26, 2016
Solution NMR characterization of apical membrane antigen 1 and small molecule interactions as a basis for designing new antimalarialsBankala Krishnarjuna, San Sui Lim, Shane M Devine, et al.
Biochemistry|November 1, 2014
Structure and dynamics of apical membrane antigen 1 from Plasmodium falciparum FVOSan Sui Lim, Wei Yang, Bankala Krishnarjuna, et al.
Journal of Medicinal Chemistry|January 7, 2015
Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffoldShane M Devine, Mark D Mulcair, Cael O Debono, et al.
Elife|July 8, 2024
Chemoproteomics validates selective targeting of <i>Plasmodium</i> M1 alanyl aminopeptidase as an antimalarial strategyCarlo Giannangelo, Matthew P Challis, Ghizal Siddiqui, et al.
The EMBO Journal|April 7, 2026
Global analysis of cancer cell responses to USP9X inhibitionPhilipp Schenk, Shane M Devine, Simon A Cobbold, et al.
Nature|April 22, 2026
Ubiquitination of glycogen and metabolites in cells and tissuesMarco Jochem, Simon A Cobbold, Craig A Goodman, et al.
Nature Communications|April 3, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVIDStefanie M Bader, Dale J Calleja, Shane M Devine, et al.
Pageof 3